Warning: Cancer patients told to avoid unauthorised 'miracle cure'
Cancer patients have been warned to avoid an unauthorised “miracle cure” sold on the internet which involves injecting modified blood.
The Health Products Regulatory Authority (HPRA) has issued the warning following concerns that the product is being imported to Ireland.
Claims have been made to lead people to believe that Globulin component Macrophage Activating Factor (GcMAF) can be used to treat cancer, HIV and autism.
It is claimed that the product modulates the immune system and cures the diseases.
“The HPRA understands from media reports that it is a blood product claimed to treat a range of conditions including cancer and autism,” a spokesperson told the Irish Examiner.
“This medicine is not authorised and, therefore, has not been tested for quality, safety, and effectiveness and its benefit/risk in the claimed indications has not been independently verified. People who have purchased this product should not start treatment,” the HPRA added.
Last year, 10,000 vials of GcMAF were seized in the UK at a production site in Cambridgeshire. A warning was issued to the public about this product (called ‘First Immune’). Britain’s Medicine and Healthcare products Regulatory Agency (MHRA) said there were concerns over the sterility of the product, and they said they believed the product to be contaminated.
One website offering information on GcMAF has claimed that GcMAF can be used in the treatment of Alzheimer’s, autism, cancer, depression, HIV, multiple sclerosis, and Parkinson’s disease.
Cancer Research UK has warned: “To suggest that there is a ‘magic bullet’ that cures all cancers is simplistic in the extreme.”